On the other hand, owing to challenges in detection due to decreased protein expression, the use of non-specific antibodies, and the contribution of alternatively spliced and differentially expressed isoforms to the immunohistochemical signal, initial reports of ERβ action and clinical importance in breast cancer were conflicting. Here, ESR2 is linked to breast cancer.